GEN1055
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GEN1055, covering 2025-12-26 to 2026-08-11. Get the full timeline:
Most recent: Clinical Trial Results: Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy [Phase 1, Phase 2]